Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DNB Bank ASA is Norway's largest financial services group with total combined assets of more than NOK 3.6 trillion. While primarily a banking institution, DNB has healthcare sector involvement through: (1) DNB Asset Management, which manages healthcare-focused mutual funds including DNB Bioteknologi (biotechnology equity fund), and (2) DNB Markets investment banking division through the DNB//Back Bay Partnership, providing strategic advisory and investment banking services to global biopharma, medtech, healthtech, diagnostic and healthcare service companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DNB Bank.